To prescribe or not to prescribe: On the regulation of pharmaceuticals in less developed countries
Author
Abstract
Suggested Citation
Download full text from publisher
As the access to this document is restricted, you may want to look for a different version below or search for a different version of it.
Other versions of this item:
- Hammer, Jeffrey S., 1991. "To prescribe or not to prescribe : on the regulation of pharmaceuticals in less developed countries," Policy Research Working Paper Series 589, The World Bank.
References listed on IDEAS
- Temin, Peter, 1983. "Costs and benefits in switching drugs from Rx to OTC," Journal of Health Economics, Elsevier, vol. 2(3), pages 187-205, December.
- George W. Torrance & Michael H. Boyle & Sargent P. Horwood, 1982. "Application of Multi-Attribute Utility Theory to Measure Social Preferences for Health States," Operations Research, INFORMS, vol. 30(6), pages 1043-1069, December.
- Torrance, George W., 1986. "Measurement of health state utilities for economic appraisal : A review," Journal of Health Economics, Elsevier, vol. 5(1), pages 1-30, March.
- Foster, S. D., 1990. "Improving the supply and use of essential drugs in sub-Saharan Africa," Policy Research Working Paper Series 456, The World Bank.
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Chatterjee, Chirantan & Mohapatra, Debi Prasad & Estay, Manuel, 2019. "From courts to markets: New evidence on enforcement of pharmaceutical bans in India," Social Science & Medicine, Elsevier, vol. 237(C), pages 1-1.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Busschbach, Jan J. V. & McDonnell, Joseph & Essink-Bot, Marie-Louise & van Hout, Ben A., 1999. "Estimating parametric relationships between health description and health valuation with an application to the EuroQol EQ-5D," Journal of Health Economics, Elsevier, vol. 18(5), pages 551-570, October.
- David Feeny, 2012.
"The Multi-attribute Utility Approach to Assessing Health-related Quality of Life,"
Chapters, in: Andrew M. Jones (ed.), The Elgar Companion to Health Economics, Second Edition, chapter 36,
Edward Elgar Publishing.
- David Feeny, 2006. "The Multi-attribute Utility Approach to Assessing Health-related Quality of Life," Chapters, in: Andrew M. Jones (ed.), The Elgar Companion to Health Economics, chapter 34, Edward Elgar Publishing.
- D. Stratmann‐Schoene & T. Kuehn & R. Kreienberg & R. Leidl, 2006. "A preference‐based index for the SF‐12," Health Economics, John Wiley & Sons, Ltd., vol. 15(6), pages 553-564, June.
- Coast, Joanna, 2009. "Maximisation in extra-welfarism: A critique of the current position in health economics," Social Science & Medicine, Elsevier, vol. 69(5), pages 786-792, September.
- Benjamin M. Craig & Jan J. V. Busschbach, 2011. "Toward a more universal approach in health valuation," Health Economics, John Wiley & Sons, Ltd., vol. 20(7), pages 864-875, July.
- Groothuis-Oudshoorn, Catharina G.M. & Chorus, Astrid M.J. & Taeke van Beekum, W. & Detmar, Symone B. & van den Hout, Wilbert B., 2006. "Modelling and estimation of valuations for the Dutch London Handicap Scale," Journal of Health Economics, Elsevier, vol. 25(6), pages 1119-1138, November.
- Zafar Hakim & Dev S. Pathak, 1999. "Modelling the EuroQol data: a comparison of discrete choice conjoint and conditional preference modelling," Health Economics, John Wiley & Sons, Ltd., vol. 8(2), pages 103-116, March.
- Coast, Joanna & Smith, Richard D. & Lorgelly, Paula, 2008. "Welfarism, extra-welfarism and capability: The spread of ideas in health economics," Social Science & Medicine, Elsevier, vol. 67(7), pages 1190-1198, October.
- Peep F. M. Stalmeier & Jan J. V. Busschbach & Leida M. Lamers & Paul F. M. Krabbe, 2005. "The gap effect: discontinuities of preferences around dead," Health Economics, John Wiley & Sons, Ltd., vol. 14(7), pages 679-685, July.
- David Parkin & Nancy Devlin, 2006.
"Is there a case for using visual analogue scale valuations in cost‐utility analysis?,"
Health Economics, John Wiley & Sons, Ltd., vol. 15(7), pages 653-664, July.
- Parkin, D. & Devlin, N., 2004. "Is there a case for using Visual Analogue Scale valuations in Cost-Utility Analysis?," Working Papers 04/03, Department of Economics, City University London.
- Marie-Josée Dion & Pierre Tousignant & Jean Bourbeau & Dick Menzies & Kevin Schwartzman, 2002. "Measurement of Health Preferences among Patients with Tuberculous Infection and Disease," Medical Decision Making, , vol. 22(1_suppl), pages 102-114, September.
- Dolan, Paul, 1996. "Modelling valuations for health states: the effect of duration," Health Policy, Elsevier, vol. 38(3), pages 189-203, December.
- Bleichrodt, Han & Quiggin, John, 1999. "Life-cycle preferences over consumption and health: when is cost-effectiveness analysis equivalent to cost-benefit analysis?," Journal of Health Economics, Elsevier, vol. 18(6), pages 681-708, December.
- Magnus Johannesson & Bengt Jönsson & Göran Karlsson, 1996. "Outcome measurement in economic evaluation," Health Economics, John Wiley & Sons, Ltd., vol. 5(4), pages 279-296, July.
- Charles M. Harvey & Lars Peter Østerdal, 2010. "Cardinal Scales for Health Evaluation," Decision Analysis, INFORMS, vol. 7(3), pages 256-281, September.
- Lima, Viviane Dias & Kopec, Jacek A., 2005. "Quantifying the effect of health status on health care utilization using a preference-based health measure," Social Science & Medicine, Elsevier, vol. 60(3), pages 515-524, February.
- Chunmei Wu & Yanhong Gong & Jiang Wu & Shengchao Zhang & Xiaoxv Yin & Xiaoxin Dong & Wenzhen Li & Shiyi Cao & Naomie Mkandawire & Zuxun Lu, 2016. "Chinese Version of the EQ-5D Preference Weights: Applicability in a Chinese General Population," PLOS ONE, Public Library of Science, vol. 11(10), pages 1-16, October.
- Arthur E. Attema & Matthijs M. Versteegh & Mark Oppe & Werner B. F. Brouwer & Elly A. Stolk, 2013. "Lead Time Tto: Leading To Better Health State Valuations?," Health Economics, John Wiley & Sons, Ltd., vol. 22(4), pages 376-392, April.
- John Brazier & Mark Deverill, 1999. "A checklist for judging preference‐based measures of health related quality of life: Learning from psychometrics," Health Economics, John Wiley & Sons, Ltd., vol. 8(1), pages 41-51, February.
- Abraham Mehrez & Amiram Gafni, 1989. "Quality-adjusted Life Years, Utility Theory, and Healthy-years Equivalents," Medical Decision Making, , vol. 9(2), pages 142-149, June.
More about this item
Keywords
pharmaceutical regulation drugs in the developing world information about pharmaceuticals--patterns of prescription;Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:socmed:v:34:y:1992:i:9:p:959-964. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu (email available below). General contact details of provider: http://www.elsevier.com/wps/find/journaldescription.cws_home/315/description#description .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.